Though hypertension is still one of the most common and manageable risk factors for cardiovascular disease (CVD), the suitable target ranges for blood pressure management remain a subject of debate. Researchers from the State University of Maringa in Brazil presented a systematic review and meta-analysis at the 2025 Scientific Sessions of the American College of Cardiology (ACC), so supporting the theory that patients with hypertension should be treated with stronger blood pressure medication.
Despite decades of research, there is still variation in treatment thresholds and goals for the management of raised blood pressure. While most physicians start treatment when the patient’s systolic blood pressure (SBP) is higher than 140 mmHg, others have adopted lower standards, particularly for individuals with comorbidities in their medical history. Cardiologist Mary Greene, MD, who helped to write this article, tries to treat every patient in a way that fits their particular situation. Read the article.
Would you like to schedule an appointment with Dr. Mary Greene?
